Induction of a cellular immune response to a foreign antigen by a recombinant Listeria monocytogenes vaccine.
about
Combined bacterial and viral treatment: a novel anticancer strategyEnhanced immunoglobulin A response and protection against Salmonella enterica serovar typhimurium in the absence of the substance P receptor.Attenuated Listeria monocytogenes: a powerful and versatile vector for the future of tumor immunotherapy.Conditional lethality yields a new vaccine strain of Listeria monocytogenes for the induction of cell-mediated immunityExisting antilisterial immunity does not inhibit the development of a Listeria monocytogenes-specific primary cytotoxic T-lymphocyte response.Noncompetitive expansion of cytotoxic T lymphocytes specific for different antigens during bacterial infection.CD8(+)-T-cell response to secreted and nonsecreted antigens delivered by recombinant Listeria monocytogenes during secondary infection.Safety and shedding of an attenuated strain of Listeria monocytogenes with a deletion of actA/plcB in adult volunteers: a dose escalation study of oral inoculation.Recombinant Listeria monocytogenes as a live vaccine vehicle for the induction of protective anti-viral cell-mediated immunityCancer immunotherapy targeting the high molecular weight melanoma-associated antigen protein results in a broad antitumor response and reduction of pericytes in the tumor vasculatureAn HLA-DRw53-restricted T-cell epitope from a novel Mycobacterium leprae protein antigen important to the human memory T-cell repertoire against M. leprae.Attenuated Yersinia enterocolitica mutant strains exhibit differential virulence in cytokine-deficient mice: implications for the development of novel live carrier vaccines.A recombinant minigene vaccine containing a nonameric cytotoxic-T-lymphocyte epitope confers limited protection against Listeria monocytogenes infectionListeria and Salmonella bacterial vectors of tumor-associated antigens for cancer immunotherapy.Antilisterial immunity includes specificity to listeriolysin O (LLO) and non-LLO-derived determinantsEnteric pathogens as vaccine vectors for foreign antigen deliveryRecombinant Listeria monocytogenes vaccination eliminates papillomavirus-induced tumors and prevents papilloma formation from viral DNAActive immunotherapy of cancer with a nonreplicating recombinant fowlpox virus encoding a model tumor-associated antigen.The next wave of recombinant and synthetic anticancer vaccines.Live attenuated Listeria monocytogenes expressing HIV Gag: immunogenicity in rhesus monkeys.The absence of lymphoid CD8+ dendritic cell maturation in L-selectin-/- respiratory compartment attenuates antiviral immunity.Live, attenuated strains of Listeria and Salmonella as vaccine vectors in cancer treatment.Antiviral cytotoxic T-cell memory by vaccination with recombinant Listeria monocytogenes.Listeria monocytogenes: at the coalface of host-pathogen research.Lessons Learned from Protective Immune Responses to Optimize Vaccines against Cryptosporidiosis.as a Vector for Cancer Immunotherapy: Current Understanding and Progress
P2860
Q26773180-1C27AD04-C75A-4BEB-83AD-558FB4755AF4Q33558850-FFB61E5D-D9D2-43D7-8BB2-27A9D8DB8CD1Q33633839-04FFBE26-52D0-4D9A-A014-6884EADDFB21Q33946547-4D7A1146-3F12-4853-8A82-781CF6D43940Q34000001-D4FA075D-4F89-4D55-AFD0-6938A097ACCEQ34000642-26DEBFF7-0C46-4408-AB59-C5BF9F2B0986Q34115899-FDF62360-0478-4ECE-8060-F59F705AB62AQ34125450-2E10D357-B2CA-4E5D-9F84-36C2D821B3A5Q34400216-9DCCDA2E-C825-4F52-B45C-81BF226C48A6Q34415243-53F13B3D-2BC7-44F5-A4EE-9B37985AECFBQ34548964-70CAC49E-43F1-4EDE-8286-B7B2BD5C433AQ34854415-55548A50-1C9A-47E9-B773-FF65B21105C6Q35489910-0D62CD08-C027-4432-B1E0-1FB9F94D38C5Q35543083-ABC568F2-2EBC-46F4-A77F-03D1BDA7F07FQ35775347-3164C4E1-A4B1-4BF3-A2E6-F560FD107BC3Q35896020-7349C489-B1BD-45DA-A7EE-97D417D0C14AQ35898471-6AFACCFC-B8FB-4776-9FC1-60062E617F14Q35990356-B77A3404-AA23-4E3E-A021-089348DA7038Q36470749-53C75999-30A0-4C00-9F06-C193CB4F9685Q36841404-BE5CD4BF-0E4A-4747-AA37-6911EB90FB05Q37013118-23800E8D-BBA6-411B-9BC0-31442DD1B2F3Q37843660-F311277C-BD1D-4219-AB1A-41D094171A96Q39874289-F606B04C-8430-4A9D-BE3F-0BC64367A57CQ42682983-F99E616B-72BD-4F23-BD3D-2E8412158B4DQ47733620-CD356DD1-C133-4F4A-940C-95FE6F92223AQ58924835-30BA390D-E8FB-421D-B318-CE1AF906AF9E
P2860
Induction of a cellular immune response to a foreign antigen by a recombinant Listeria monocytogenes vaccine.
description
1992 nî lūn-bûn
@nan
1992 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Induction of a cellular immune ...... isteria monocytogenes vaccine.
@ast
Induction of a cellular immune ...... isteria monocytogenes vaccine.
@en
Induction of a cellular immune ...... isteria monocytogenes vaccine.
@nl
type
label
Induction of a cellular immune ...... isteria monocytogenes vaccine.
@ast
Induction of a cellular immune ...... isteria monocytogenes vaccine.
@en
Induction of a cellular immune ...... isteria monocytogenes vaccine.
@nl
prefLabel
Induction of a cellular immune ...... isteria monocytogenes vaccine.
@ast
Induction of a cellular immune ...... isteria monocytogenes vaccine.
@en
Induction of a cellular immune ...... isteria monocytogenes vaccine.
@nl
P2093
P1476
Induction of a cellular immune ...... isteria monocytogenes vaccine.
@en
P2093
Brassell SA
Paterson Y
Portnoy DA
P407
P577
1992-07-01T00:00:00Z